Warning Letters Can Reduce Quetiapine Overprescribing
By Elana Gotkine HealthDay Reporter
MONDAY, April 29, 2024 -- For patients with dementia, letters warning primary care physicians (PCPs) regarding overprescribing can reduce quetiapine prescriptions, according to a study published online April 25 in JAMA Network Open.
Michelle Harnisch, from the London School of Economics and Political Science, and colleagues conducted a secondary analysis of a randomized clinical trial of overprescribing letters that began in April 2015 and involved the highest-volume PCP prescribers of quetiapine in original Medicare. PCPs were randomly assigned to receive a placebo letter or three overprescribing warning letters stating that their prescribing of quetiapine was high and under review (2,528 and 2,527 PCPs, respectively). These PCPs accounted for 84,881 patients with dementia living in nursing homes and 261,288 community-dwelling patients with dementia.
The researchers found that quetiapine use was reduced with the intervention among nursing home patients and community-dwelling patients (adjusted differences, −0.7 and −1.5 days, respectively). No adverse effects were observed on cognitive function, behavioral symptoms, depression, metabolic diagnoses, or more severe outcomes such as hospitalization and death.
"Our results highlight the value of simple deprescribing interventions for clinicians, specialty societies, and regulators seeking to improve the quality of dementia care," the authors write. "Related interventions could promote guideline-concordant care more broadly."
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted April 2024
Read this next
Allergy-Related Psychological Distress Common
TUESDAY, July 2, 2024 -- Psychological distress related to food allergies (FA) is common globally, according to a study published online June 21 in Allergy. Rebecca C...
Self-Administered Gerocognitive Exam Improves Detection of Cognitive Issues in Primary Care
TUESDAY, July 2, 2024 -- A self-administered gerocognitive examination (SAGE) is easily incorporated into primary care provider (PCP) visits, and its use significantly increases...
Transgender, Gender-Diverse Adults Face Higher Risk for Experiencing Violence
TUESDAY, July 2, 2024 -- Transgender and gender-diverse individuals have a higher risk for experiencing all forms of violence compared with cisgender women, according to a study...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.